Jabra Achieve 17 63DRWC-R User Manual page 66

Table of Contents

Advertisement

Usability Engineering was performed in compliance with IEC 62366-1:2015
The devices covered in this user guide passed all tests for the relevant non-clinical performance testing and
biological endpoints, namely cytotoxicity (ISO 10993-05:2009), sensitization, and intracutaneous reactivity (ISO
10993-10:2010).
Similarly, usability testing and software verification and validation demonstrated mitigation of risks to an
acceptable level as well as reasonable assurance of safe and effective device performance.
Clinical data (US only)
Devices have been evaluated clinically through equivalence to equivalent devices and similar devices on the
market with similar intended purpose, e.g., to compensate for hearing impairment by amplifying and transmitting
sound to the ear.
Based on technical and clinical data presented for the device in question, the equivalent predecessor, and
generally similar devices, it is concluded to support the clinical performance expressed in user needs and claims.
The clinical data leaves no questions open regarding clinical performance and is for this reason deemed
sufficient.
66
Regulatory information

Advertisement

Table of Contents
loading

Table of Contents